Harnesses genetics and iPSCs to engineer cell therapies that replace defective cells for treating various diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Vita Therapeutics is a cell engineering company that harnesses the power of genetics and induced pluripotent stem cells (iPSCs) to create specific cell types designed to replace defective cells in patients. The company focuses on both autologous (patient-specific) and allogeneic (universal) approaches to deliver these engineered cells as therapies for various diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Vita Therapeutics Management Team
Investors
Cambrian Biopharma
Cedars Sinai Medical Center
Maryland Technology Development Corporation (TEDCO)
Riptide Ventures
Solve FSHD
Vita Therapeutics Valuations & Financials
View real-time NPM data on Vita Therapeutics stock including daily Vita Therapeutics stock price estimates, valuation history, and historical share price information. Access Vita Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Vita Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Vita Therapeutics? Get in touch to learn more.
Similar Companies
like Vita Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Rentable
Commerce & Marketplaces
Digital platform streamlines apartment hunting by connecting renters with available listings through an intuitive search interface.
Xontogeny
That supports early-stage healthcare technologies with funding, guidance, and operational expertise to advance development.
ReCarbon
Climate & Sustainability
Converts greenhouse gases into clean hydrogen and syngas using plasma technology, enabling industrial decarbonization and sustainable fuel production.
Frontify
Brand management platform that centralizes digital assets and guidelines, enabling teams to create and maintain consistent brand materials.
LibLab
Enterprise Software
Platform automates SDK generation and maintenance across multiple programming languages, streamlining API integration for developers.
Employment Hero
All-in-one HR platform streamlines payroll, benefits, and workforce management through an integrated system for businesses.
Rarify
Web3 & Digital Assets
Builds immersive digital ecosystems and platforms that enable creators to transform content into engaging experiences for secure collaboration.
Curama
Online marketplace connecting homeowners with service professionals for household tasks like cleaning, moving and repairs.
FAQ
We have answers
Vita Therapeutics stock does not trade on public stock exchanges. Vita Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Vita Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Vita Therapeutics Stock does not trade on public stock exchanges. In order to sell Vita Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Vita Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Vita Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Vita Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Vita Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Vita Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Vita Therapeutics is a private company and has not had an IPO. There is currently no Vita Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Vita Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
